Systematic biochemical analysis of somatic missense mutations in DNA polymerase β found in prostate cancer reveal alteration of enzymatic function

DNA polymerase β is essential for short‐patch base excision repair. We have previously identified 20 somatic pol β mutations in prostate tumors, many of them missense. In the current article we describe the effect of all of these somatic missense pol β mutations (p.K27N, p.E123K, p.E232K, p.P242R, p.E216K, p.M236L, and the triple mutant p.P261L/T292A/I298T) on the biochemical properties of the polymerase in vitro, following bacterial expression and purification of the respective enzymatic variants. We report that all missense somatic pol β mutations significantly affect enzyme function. Two of the pol β variants reduce catalytic efficiency, while the remaining five missense mutations alter the fidelity of DNA synthesis. Thus, we conclude that a significant proportion (9 out of 26; 35%) of prostate cancer patients have functionally important somatic mutations of pol β. Many of these missense mutations are clonal in the tumors, and/or are associated with loss of heterozygosity and microsatellite instability. These results suggest that interfering with normal polymerase β function may be a frequent mechanism of prostate tumor progression. Furthermore, the availability of detailed structural information for pol β allows understanding of the potential mechanistic effects of these mutants on polymerase function. Hum Mutat 32:1–9, 2011. © 2011 Wiley‐Liss, Inc.

[1]  M. Kashani-Sabet,et al.  Differential gene expression in human cancer cells resistant to cisplatin. , 1989, Cancer investigation.

[2]  T. Kunkel.  Biological asymmetries and the fidelity of eukaryotic DNA replication , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  T. Shuin,et al.  DNA Polymerase β Gene Mutation in Human Prostate Cancer , 1994 .

[4]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[5]  J. Kraut,et al.  Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity. , 1996, Biochemistry.

[6]  Samuel H. Wilson,et al.  Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. , 1997, Biochemistry.

[7]  B. Preston,et al.  Increased Activity and Fidelity of DNA Polymerase β on Single-nucleotide Gapped DNA* , 1997, The Journal of Biological Chemistry.

[8]  R. V. Prasad,et al.  Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. , 1998, The Journal of biological chemistry.

[9]  W. Beard,et al.  Structural insights into DNA polymerase beta fidelity: hold tight if you want it right. , 1998, Chemistry & biology.

[10]  M. Diefenbach,et al.  Prostate Cancer Risk Assessment Program , 1999 .

[11]  M. Diefenbach,et al.  Prostate cancer risk assessment program. A model for the early detection of prostate cancer. , 1999, Oncology.

[12]  J. Sweasy,et al.  Involvement of phenylalanine 272 of DNA polymerase beta in discriminating between correct and incorrect deoxynucleoside triphosphates. , 1999, Biochemistry.

[13]  M. Lieber,et al.  Efficient Processing of DNA Ends during Yeast Nonhomologous End Joining , 1999, The Journal of Biological Chemistry.

[14]  J. Sweasy,et al.  3′-Azido-3′-deoxythymidine-resistant Mutants of DNA Polymerase β Identified by in Vivo Selection* , 1999, The Journal of Biological Chemistry.

[15]  Y. Kubota,et al.  Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase β , 2000, The EMBO journal.

[16]  J. Sweasy,et al.  A DNA polymerase beta mutator mutant with reduced nucleotide discrimination and increased protein stability. , 2001, Biochemistry.

[17]  K. Eckert,et al.  Threonine 79 Is a Hinge Residue That Governs the Fidelity of DNA Polymerase β by Helping to Position the DNA within the Active Site* , 2002, The Journal of Biological Chemistry.

[18]  M. Goodman.  Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.

[19]  Xiao-Ping Yang,et al.  Loss of DNA Polymerase β Stacking Interactions with Templating Purines, but Not Pyrimidines, Alters Catalytic Efficiency and Fidelity* , 2002, The Journal of Biological Chemistry.

[20]  L. Loeb,et al.  Deregulated DNA polymerase β induces chromosome instability and tumorigenesis , 2002 .

[21]  F. Hanaoka,et al.  A Role for DNA Polymerase β in Mutagenic UV Lesion Bypass* , 2002, The Journal of Biological Chemistry.

[22]  E. Friedberg,et al.  DNA damage and repair , 2003, Nature.

[23]  Samuel H. Wilson,et al.  Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. , 2003, Cancer research.

[24]  J. Sweasy,et al.  Is There a Link Between DNA Polymerase Beta and Cancer? , 2004, Cell cycle.

[25]  J. Sweasy,et al.  The D246V mutant of DNA polymerase beta misincorporates nucleotides: evidence for a role for the flexible loop in DNA positioning within the active site. , 2004, The Journal of biological chemistry.

[26]  J. Sweasy,et al.  A DNA polymerase β mutant from colon cancer cells induces mutations , 2004 .

[27]  J. Sweasy,et al.  A DNA polymerase beta mutant from colon cancer cells induces mutations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Lim,et al.  Analysis of bgl Operon Structure and Characterization of β-Glucosidase from Pectobacterium carotovorum subsp. carotovorum LY34 , 2004, Bioscience, biotechnology, and biochemistry.

[29]  Samuel H. Wilson,et al.  Dynamic characterization of a DNA repair enzyme: NMR studies of [methyl-13C]methionine-labeled DNA polymerase beta. , 2004, Biochemistry.

[30]  K. Eckert,et al.  Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. , 2005, Biochemistry.

[31]  Chemotherapeutic nucleoside analogues and DNA polymerase β , 2005 .

[32]  Samuel H. Wilson,et al.  Structural insight into the DNA polymerase beta deoxyribose phosphate lyase mechanism. , 2005, DNA repair.

[33]  J. Sweasy,et al.  Is Base Excision Repair a Tumor Suppressor Mechanism? , 2006, Cell cycle.

[34]  E. Guinó,et al.  Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer , 2006, Clinical Cancer Research.

[35]  T. Eisen,et al.  Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. , 2007, Human molecular genetics.

[36]  J. Sweasy,et al.  The E295K DNA Polymerase Beta Gastric Cancer-Associated Variant Interferes with Base Excision Repair and Induces Cellular Transformation , 2007, Molecular and Cellular Biology.

[37]  M. Pike,et al.  No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned. , 2008, Human molecular genetics.

[38]  J. Sweasy,et al.  The Leu22Pro tumor-associated variant of DNA polymerase beta is dRP lyase deficient , 2007, Nucleic acids research.

[39]  K. Mimori,et al.  A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer , 2009, Journal of surgical oncology.

[40]  N. Makridakis,et al.  Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif , 2009, Human mutation.

[41]  Daniel Zelterman,et al.  DNA polymerase β is critical for mouse meiotic synapsis , 2010, The EMBO journal.